The value of growth hormone supplements in ART for poor ovarian responders

Fertility and Sterility

Volumn 96, Issue 5, 2011, Pages 1069-1076

  De Ziegler, Dominique ^a   Streuli, Isabelle ^a,b   Meldrum, David R ^c   Chapron, Charles ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

aging; ART; assisted reproductive technologies; controlled ovarian stimulation; COS; Growth hormone; ovarian failure; poor response

Indexed keywords

FOLLITROPIN; GONADOTROPIN; HUMAN GROWTH HORMONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; SOMATOMEDIN B; SOMATOMEDIN C;

ASSISTED REPRODUCTIVE TECHNOLOGY; CONTROLLED OVARIAN STIMULATION; ENDOMETRIUM TUMOR; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY FOLLICLE FLUID; OVARY FUNCTION; POOR OVARIAN RESPONSE; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 80055021597     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.09.049     Document Type: Article

References (94)

1. D.R. Meldrum, R.J. Chang, D. de Ziegler, W.B. Schoolcraft, R.T. Scott Jr., and A. Pellicer Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs? Fertil Steril 92 2009 13 18
2. D. Kyrou, E.M. Kolibianakis, C.A. Venetis, E.G. Papanikolaou, J. Bontis, and B.C. Tarlatzis How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Fertil Steril 91 2009 749 766
3. J.M. Duffy, G. Ahmad, L. Mohiyiddeen, L.G. Nardo, and A. Watson Growth hormone for in vitro fertilization Cochrane Database Syst Rev 1 2010 CD000099
4. E.M. Kolibianakis, C.A. Venetis, K. Diedrich, B.C. Tarlatzis, and G. Griesinger Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis Hum Reprod Update 15 2009 613 622
5. E.J. Owen, C. West, B.A. Mason, and H.S. Jacobs Co-treatment with growth hormone of sub-optimal responders in IVF-ET Hum Reprod 6 1991 524 528
6. E.J. Owen, Z. Shoham, B.A. Mason, H. Ostergaard, and H.S. Jacobs Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial Fertil Steril 56 1991 1104 1110
7. A.P. Ferraretti, A. La Marca, B.C. Fauser, B. Tarlatzis, G. Nargund, L. Gianaroli ESHRE working group on Poor Ovarian Response Definition ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 2011 1616 1624
8. F.J. Broekmans, M.R. Soules, and B.C. Fauser Ovarian aging: mechanisms and clinical consequences Endocr Rev 30 2009 465 493
9. R.G. Edwards Test-tube babies, 1981 Nature 293 1981 253 256
10. H.W. Jones Jr., G.S. Jones, M.C. Andrews, A. Acosta, C. Bundren, and J. Garcia The program for in vitro fertilization at Norfolk Fertil Steril 38 1982 14 21
11. P. Serafini, B. Yee, J. Vargyas, and R.P. Marrs Development of multiple ovarian follicles for in vitro fertilization in a patient with an undiagnosed ectopic pregnancy Fertil Steril 43 1985 656 658
12. N.S. Macklon, R.L. Stouffer, L.C. Giudice, and B.C. Fauser The science behind 25 years of ovarian stimulation for in vitro fertilization Endocr Rev 27 2006 170 207
13. M.H. Lin, R. Kuo-Kuang Lee, S.H. Li, C.H. Lu, F.J. Sun, and Y.M. Hwu Sperm chromatin structure assay parameters are not related to fertilization rates, embryo quality, and pregnancy rates in in vitro fertilization and intracytoplasmic sperm injection, but might be related to spontaneous abortion rates Fertil Steril 90 2008 352 359
14. M. Bungum, M. Spano, P. Humaidan, P. Eleuteri, M. Rescia, and A. Giwercman Sperm chromatin structure assay parameters measured after density gradient centrifugation are not predictive for the outcome of ART Hum Reprod 23 2008 4 10
15. A.K. Nangia, B. Luke, J.F. Smith, W. Mak, and J.E. Stern National study of factors influencing assisted reproductive technology outcomes with male factor infertility Fertil Steril 96 2011 609 614
16. S. Oehninger Ovulation induction in IVF Minerva Ginecol 63 2011 137 156
17. S. Shanbhag, L. Aucott, S. Bhattacharya, M.A. Hamilton, and A.R. McTavish Interventions for "poor responders" to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst Rev 1 2007 CD004379
18. C. Siemer, T. Smiljakovic, M. Bhojwani, C. Leiding, W. Kanitz, and M. Kubelka Analysis of mRNA associated factors during bovine oocyte maturation and early embryonic development Mol Reprod Dev 76 2009 1208 1219
19. M.K. Kang, and S.J. Han Post-transcriptional and post-translational regulation during mouse oocyte maturation BMB Rep 44 2011 147 157
20. F. Paulini, and E.O. Melo The role of oocyte-secreted factors GDF9 and BMP15 in follicular development and oogenesis Reprod Domest Anim 46 2011 354 361
21. H.M. Fraser Regulation of the ovarian follicular vasculature Reprod Biol Endocrinol 4 2006 18
22. K.T. Jones Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age Hum Reprod Update 14 2008 143 158
23. O. Epifano, and J. Dean Genetic control of early folliculogenesis in mice Trends Endocrinol Metab 13 2002 169 173
24. P.D. Lee, L.C. Giudice, C.A. Conover, and D.R. Powell Insulin-like growth factor binding protein-1: recent findings and new directions Proc Soc Exp Biol Med 216 1997 319 357
25. K.D. Schoyer, H.C. Liu, S. Witkin, Z. Rosenwaks, and S.D. Spandorfer Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome Fertil Steril 88 2007 139 144
26. M. Bahceci, U. Ulug, E. Turan, and M.A. Akman Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist Eur J Obstet Gynecol Reprod Biol 130 2007 93 98
27. C.J. Kelly, S.R. Stenton, and H. Lashen Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis Hum Reprod Update 17 2011 4 16
28. G.R. Pereira, P.L. Lorenzo, G.F. Carneiro, B.A. Ball, P.B. Goncalves, and L.M. Pegoraro The effect of growth hormone (GH) and insulin-like growth factor-I (IGF-I) on in vitro maturation of equine oocytes Zygote 2011 1 8
29. Y.J. Menezo, B. Nicollet, J. Rollet, and A. Hazout Pregnancy and delivery after in vitro maturation of naked ICSI-GV oocytes with GH and transfer of a frozen thawed blastocyst: case report J Assist Reprod Genet 23 2006 47 49
30. B.J. Thompson, C.A. Shang, and M.J. Waters Identification of genes induced by growth hormone in rat liver using cDNA arrays Endocrinology 141 2000 4321 4324
31. V.J. Hall, D. Compton, P. Stojkovic, M. Nesbitt, M. Herbert, and A. Murdoch Developmental competence of human in vitro aged oocytes as host cells for nuclear transfer Hum Reprod 22 2007 52 62
32. F. Otsuka, K.J. McTavish, and S. Shimasaki Integral role of GDF-9 and BMP-15 in ovarian function Mol Reprod Dev 78 2011 9 21
33. T. Dailey, B. Dale, J. Cohen, and S. Munne Association between nondisjunction and maternal age in meiosis-II human oocytes Am J Hum Genet 59 1996 176 184
34. C. Mendoza, E. Ruiz-Requena, E. Ortega, N. Cremades, F. Martinez, and R. Bernabeu Follicular fluid markers of oocyte developmental potential Hum Reprod 17 2002 1017 1022
35. E.Y. Adashi, C.E. Resnick, A.J. D'Ercole, M.E. Svoboda, and J.J. Van Wyk Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function Endocr Rev 6 1985 400 420
36. J.B. Davoren, J.W. Hsueh, and C.H. Li Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells Am J Physiol 249 1985 E26 E33
37. R. Homburg, A. Eshel, H.I. Abdalla, and H.S. Jacobs Growth hormone facilitates ovulation induction by gonadotrophins Clin Endocrinol (Oxf) 29 1988 113 117
38. C. Bergh, T. Hillensjo, M. Wikland, L. Nilsson, G. Borg, and L. Hamberger Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study Fertil Steril 62 1994 113 120
39. J. Dor, D.S. Seidman, E. Amudai, D. Bider, D. Levran, and S. Mashiach Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study Hum Reprod 10 1995 40 43
40. G.L. Zhuang, S.X. Wong, and C.Q. Zhou [The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer] Zhonghua Fu Chan Ke Za Zhi 29 1994 471 474 510
41. A. Suikkari, V. MacLachlan, R. Koistinen, M. Seppala, and D. Healy Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology Fertil Steril 65 1996 800 805
42. J. Tesarik, A. Hazout, and C. Mendoza Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone Hum Reprod 20 2005 2536 2541
43. T. Kucuk, H. Kozinoglu, and A. Kaba Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial J Assist Reprod Genet 25 2008 123 127
44. J. Tapanainen, H. Martikainen, R. Voutilainen, M. Orava, A. Ruokonen, and L. Rönnberg Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells Fertil Steril 58 1992 726 732
45. J.S. Younis, A. Simon, R. Koren, D. Dorembus, J.G. Schenker, and N. Laufer The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study Fertil Steril 58 1992 575 580
46. B.C. Fauser, and A.M. Van Heusden Manipulation of human ovarian function: physiological concepts and clinical consequences Endocr Rev 18 1997 71 106
47. J.P. Toner, C.B. Philput, G.S. Jones, and S.J. Muasher Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age Fertil Steril 55 1991 784 791
48. S.D. Spandorfer, K. Bendikson, K. Dragisic, G. Schattman, O.K. Davis, and Z. Rosenwaks Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes Fertil Steril 87 2007 74 76
49. L. Gianaroli, M.C. Magli, G. Cavallini, A. Crippa, A. Capoti, and S. Resta Predicting aneuploidy in human oocytes: key factors which affect the meiotic process Hum Reprod 25 2010 2374 2386
50. A.S. Setti, D.P. de Almeida Ferreira Braga, R. de Cássia Savio Figueira Figueira, M. de Castro Azevedo, A. Iaconelli Jr., and E. Borges Jr. Are poor responders patients at higher risk for producing aneuploid embryos in vitro? J Assist Reprod Genet 28 2011 399 404
51. M.L. Haadsma, H. Groen, T.M. Mooij, C.W. Burger, F.J. Broekmans, C.B. Lambalk OMEGA Project Group Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation Reprod Biomed Online 20 2010 191 200
52. B. Kumbak, U. Ulug, B. Erzik, H. Akbas, and M. Bahceci Early clinical pregnancy loss rate in poor responder patients does not change compared to age-matched normoresponders Fertil Steril 91 2009 106 109
53. I.A. van Rooij, L.F. Bancsi, F.J. Broekmans, C.W. Looman, J.D. Habbema, and E.R. te Velde Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization Fertil Steril 79 2003 482 488
54. M.A. Esposito, C. Coutifaris, and K.T. Barnhart A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women Hum Reprod 17 2002 118 123
55. P. De Sutter, and M. Dhont Poor response after hormonal stimulation for in vitro fertilization is not related to ovarian aging Fertil Steril 79 2003 1294 1298
56. S.L. Broer, M. Dolleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
57. I.M. Matalliotakis, H. Cakmak, N. Mahutte, Y. Fragouli, A. Arici, and D. Sakkas Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility Fertil Steril 88 2007 1568 1572
58. D. de Ziegler, V. Gayet, F.X. Aubriot, P. Fauque, I. Streuli, and J.P. Wolf Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes Fertil Steril 94 2010 2796 2799
59. M. Al-Azemi, A.L. Bernal, J. Steele, I. Gramsbergen, D. Barlow, and S. Kennedy Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis Hum Reprod 15 2000 72 75
60. E.S. Surrey, K.M. Silverberg, M.W. Surrey, and W.B. Schoolcraft Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis Fertil Steril 78 2002 699 704
61. S.L. Reinblatt, L. Ishai, F. Shehata, W.Y. Son, T. Tulandi, and B. Almog Effects of ovarian endometrioma on embryo quality Fertil Steril 95 2011 2700 2702
62. K. Barnhart, R. Dunsmoor-Su, and C. Coutifaris Effect of endometriosis on in vitro fertilization Fertil Steril 77 2002 1148 1155
63. D. de Ziegler, J. de Mouzon, P. Fauque, M. Zanette, A. Marszalek, and V. Blanchet Multiplying recipients paired with oocyte donors optimizes the use of donated oocytes Fertil Steril 95 2011 1633 1638
64. M.C. Yih, S.D. Spandorfer, and Z. Rosenwaks Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Fertil Steril 83 2005 24 29
65. V.M. Sopelak, R.L. Collins, and G.D. Hodgen Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose J Clin Endocrinol Metab 62 1986 557 562
66. R. Abbasi, D. Kenigsberg, D. Danforth, R.J. Falk, and G.D. Hodgen Cumulative ovulation rate in human menopausal/human chorionic gonadotropin-treated monkeys: "step-up" versus "step-down" dose regimens Fertil Steril 47 1987 1019 1024
67. S.E. Lanzendorf, K. Gordon, J. Toner, M.C. Mahony, P. Kolm, and G.D. Hodgen Prediction of ovarian response to exogenous gonadotropin stimulation: utilization for collection of primate oocytes for fertilization in vitro Theriogenology 44 1995 641 648
68. A. Hourvitz, E. Maman, M. Brengauz, R. Machtinger, and J. Dor In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities." Fertil Steril 94 2010 496 501
69. X. Xing, H. Zhao, M. Li, M. Sun, Y. Li, and Z.J. Chen Morphologically abnormal oocytes not capable of fertilization despite repeated strategies Fertil Steril 95 2011 2435.e5-7
70. B.S. Shapiro, K.S. Richter, D.C. Harris, and S.T. Daneshmand Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after one or more failed attempts Fertil Steril 76 2001 538 542
71. K. Harper, M. Proctor, and E. Hughes Growth hormone for in vitro fertilization Cochrane Database Syst Rev 3 2003 CD000099
72. G. Ahmad, J. Brown, J.M. Duffy, L.G. Nardo, and A. Watson Growth hormone for in vitro fertilization Cochrane Database Syst Rev 4 2009 CD000099
73. R.G. Edwards, and P.C. Steptoe Current status of in-vitro fertilisation and implantation of human embryos Lancet 2 1983 1265 1269
74. J. de Mouzon, V. Goossens, S. Bhattacharya, J.A. Castilla, A.P. Ferraretti, V. Korsak European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE) Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE Hum Reprod 25 2010 1851 1862
75. S. Sunderam, J. Chang, L. Flowers, A. Kulkarni, G. Sentelle, G. Jeng Centers for Disease Control and Prevention (CDC) Assisted reproductive technology surveillance - United States, 2006 MMWR Surveill Summ 58 2009 1 25
76. G. Nargund, J. Waterstone, J. Bland, Z. Philips, J. Parsons, and S. Campbell Cumulative conception and live birth rates in natural (unstimulated) IVF cycles Hum Reprod 16 2001 259 262
77. M. Schimberni, F. Morgia, J. Colabianchi, A. Giallonardo, C. Piscitelli, and P. Giannini Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles Fertil Steril 92 2009 1297 1301
78. C. Rongieres-Bertrand, F. Olivennes, C. Righini, R. Fanchin, J. Taieb, and S. Hamamah Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation Hum Reprod 14 1999 683 688
79. I.J. Kadoch, R. Fanchin, N. Frydman, A. Le Du, and R. Frydman Controlled natural cycle IVF: a novel approach for a dominant follicle during an in-vitro maturation cycle Reprod Biomed Online 14 2007 598 601
80. M.F. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, and F.J. Broekmans Mild ovarian stimulation for IVF Hum Reprod Update 15 2009 13 29
81. B.C. Fauser, G. Nargund, A.N. Andersen, R. Norman, B. Tarlatzis, and J. Boivin Mild ovarian stimulation for IVF: 10 years later Hum Reprod 25 2010 2678 2684
82. D. Warburton Biological aging and the etiology of aneuploidy Cytogenet Genome Res 111 2005 266 272
83. L. Liu, and D.L. Keefe Defective cohesin is associated with age-dependent misaligned chromosomes in oocytes Reprod Biomed Online 16 2008 103 112
84. C. Blockeel, V. Schutyser, A. De Vos, W. Verpoest, M. De Vos, and C. Staessen Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation Reprod Biomed Online 17 2008 848 854
85. V.I. Farfalli, M.C. Magli, A.P. Ferraretti, and L. Gianaroli Role of aneuploidy on embryo implantation Gynecol Obstet Invest 64 2007 161 165
86. D.R. Meldrum, M.D. Sammel, and K. Barnhart The null hypothesis: closing the gap between good intentions and good studies Fertil Steril 96 2011 6 10.e12
87. T. Freour, D. Masson, S. Mirallie, M. Jean, K. Bach, and T. Dejoie Active smoking compromises IVF outcome and affects ovarian reserve Reprod Biomed Online 16 2008 96 102
88. W. Schoolcraft, T. Schlenker, M. Gee, J. Stevens, and L. Wagley Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol Fertil Steril 67 1997 93 97
89. J.L. Yovich, and J.D. Stanger Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF Reprod Biomed Online 21 2010 37 49
90. A. Hazout, A. Junca, Y. Menezo, J. Demouzon, and P. Cohen-Bacrie Effect of growth hormone on oocyte competence in patients with multiple IVF failures Reprod Biomed Online 18 2009 664 670
91. S.J. Olshansky, and T.T. Perls New developments in the illegal provision of growth hormone for "anti-aging" and bodybuilding J Am Med Assoc 299 2008 2792 2794
92. E. Taylor Illegal human growth hormone markets. Issues in controlling online drug sales and advertising J Leg Med 29 2008 237 253
93. H. Liu, D.M. Bravata, I. Olkin, A. Friedlander, V. Liu, and B. Roberts Systematic review: the effects of growth hormone on athletic performance Ann Intern Med 148 2008 747 758
94. B. Sauter Growth hormone for "antiaging J Am Med Assoc 295 2006 889 author reply 889-90